Novartis Sees Promise, to the tune of $10B, in The Medicines Company

Novartis will help push further testing and production of Inclisiran, the first cholesterol-lowering drug created by The Medicines Company to treat cardiovascular and other related diseases. The treatment hasn’t been approved by the FDA or any other regulatory authority yet, but The Medicines Company is already moving forward...